Axon Enterprise (NASDAQ:AXON) Stock Price Up 12.5% on Analyst Upgrade

Key Points

• Axon shares jumped 12.5% after JPMorgan raised its price target to $755 and maintained an overweight rating, sending the stock to about $434 intraday from a prior close near $386.
• Operational momentum remains strong: Q1 revenue was roughly $807M (≈34% YoY), AI and counter‑drone products showed outsized growth, and management raised FY‑2026 revenue guidance to 30–32% while targeting about $450M in free cash flow.
• Sentiment is mixed — MarketBeat shows a consensus "Moderate Buy" (consensus target ≈$722.69) with dispersion among analysts and several insiders selling shares (≈13,855 shares, ~$7.1M over 90 days), while institutions own about 79% of the stock.

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report)'s stock price shot up 12.5% on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $750.00 to $755.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Axon Enterprise traded as high as $433.57 and last traded at $434.1860. 912,398 shares were traded during mid-day trading, a decline of 12% from the average session volume of 1,039,980 shares. The stock had previously closed at $385.86.

A number of other brokerages have also commented on AXON. Weiss Ratings lowered Axon Enterprise from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, April 10th. Citigroup reiterated a "buy" rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Wall Street Zen upgraded Axon Enterprise from a "sell" rating to a "hold" rating in a research report on Saturday, February 28th. Piper Sandler lowered their price objective on Axon Enterprise from $690.00 to $674.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Needham & Company LLC lowered their price objective on Axon Enterprise from $870.00 to $600.00 and set a "buy" rating for the company in a research report on Friday, February 20th. Sixteen equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $722.69.

Insiders Place Their Bets

In related news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the transaction, the insider owned 55,588 shares of the company's stock, valued at $29,740,135.88. This trade represents a 3.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Jennifer H. Mak sold 1,500 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total transaction of $860,175.00. Following the transaction, the chief accounting officer owned 12,240 shares of the company's stock, valued at approximately $7,019,028. This represents a 10.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 13,855 shares of company stock worth $7,109,828 over the last ninety days. Company insiders own 4.40% of the company's stock.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Company raised FY‑2026 revenue growth guidance to 30%–32% and is targeting about $450M in free cash flow (and >$600M operating cash flow); management also reiterated a strong adjusted‑EBITDA margin target, signaling durable high‑growth, cash‑generative outlooks. Axon raises 2026 revenue growth outlook to 30%-32% while targeting about $450M in free cash flow
• Positive Sentiment: Q1 revenue of ~$807M (+34% YoY) topped revenue estimates and marked Axon’s ninth straight quarter of 30%+ growth; software & services and premium AI products drove the beat. Axon reports Q1 2026 revenue of $807 million, up 34% year over year
• Positive Sentiment: AI and counter‑drone businesses are accelerating: AI product revenue was reported up ~700% YoY and counter‑drone bookings surged (~500%), giving analysts a new growth/valuation lens beyond Tasers and body cameras. This momentum is a visible growth catalyst. Axon Counter Drone And AI Growth Recast Valuation And Risk Profile
• Positive Sentiment: Large municipal procurement continues to support device demand — Baltimore approved a ~$153M contract for upgraded body cameras and Tasers, showing persistent public‑sector spending tailwinds. Baltimore police to get upgraded body-worn cameras, Tasers after city approves $153 million contract
• Neutral Sentiment: Analyst reactions are broadly constructive: several firms maintained or raised ratings and price targets (JPMorgan raised its target, Needham, William Blair and others kept Buy/Overweight stances), which supports sentiment but reveals dispersion in valuation views. JPMorgan Chase & Co. raises price target Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
• Negative Sentiment: Earnings/margin nuance: while revenue beat, some reports flagged an EPS miss or margin pressure tied to tariffs and cost headwinds; that explains caution among some investors despite top‑line strength. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: Some firms trimmed price targets (Piper Sandler, Citizens JMP lowered targets), indicating continued debate over valuation after a recent multi‑month share decline. Piper Sandler lowers price target Citizens JMP lowers price target

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Stone House Investment Management LLC acquired a new position in Axon Enterprise during the third quarter valued at approximately $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the third quarter valued at approximately $29,000. Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at about $37,000. Root Financial Partners LLC bought a new position in shares of Axon Enterprise during the 3rd quarter valued at about $34,000. Finally, Creative Financial Designs Inc. ADV bought a new position in shares of Axon Enterprise during the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The firm has a market cap of $34.39 billion, a P/E ratio of 280.85, a PEG ratio of 8.12 and a beta of 1.44. The company has a fifty day moving average price of $452.24 and a two-hundred day moving average price of $529.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million for the quarter, compared to analysts' expectations of $755.29 million. During the same quarter in the previous year, the business posted $2.08 EPS. Axon Enterprise's revenue for the quarter was up 38.5% on a year-over-year basis. Equities analysts anticipate that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.